2018
Neutrophil lymphocyte ratio and transarterial chemoembolization in neuroendocrine tumor metastases
McDermott SM, Saunders ND, Schneider EB, Strosberg D, Onesti J, Dillhoff M, Schmidt CR, Shirley LA. Neutrophil lymphocyte ratio and transarterial chemoembolization in neuroendocrine tumor metastases. Journal Of Surgical Research 2018, 232: 369-375. PMID: 30463743, DOI: 10.1016/j.jss.2018.06.058.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAgedAged, 80 and overChemoembolization, TherapeuticFemaleFollow-Up StudiesHumansKaplan-Meier EstimateLeukocyte CountLiver NeoplasmsLymphocytesMaleMiddle AgedNeuroendocrine TumorsNeutrophilsPreoperative PeriodPrognosisResponse Evaluation Criteria in Solid TumorsRetrospective StudiesYoung AdultConceptsMedian overall survivalMetastatic neuroendocrine tumorsTransarterial chemoembolizationOverall survivalNeuroendocrine tumorsSingle tertiary medical centerCancer-related treatmentTertiary medical centerNeuroendocrine tumor metastasesPotential treatment strategyElevated NLRLiver metastasesNLR valuesIndependent predictorsBlood workLymphocyte ratioEntire cohortTreatment strategiesPostprocedural careMedical CenterPatientsMultivariate analysisNLRTumor metastasisChemoembolization
2013
Post-treatment surveillance of patients with colorectal cancer with surgically treated liver metastases
Hyder O, Dodson R, Mayo S, Schneider E, Weiss M, Herman J, Wolfgang C, Pawlik T. Post-treatment surveillance of patients with colorectal cancer with surgically treated liver metastases. Surgery 2013, 154: 256-265. PMID: 23889953, PMCID: PMC4048030, DOI: 10.1016/j.surg.2013.04.021.Peer-Reviewed Original ResearchConceptsColorectal liver metastasesMagnetic resonance imagingPositron emission tomographyPost-treatment surveillanceComputed tomographyLiver metastasesLiver resectionSurveillance imagingTreatment of CRLMMore frequent surveillanceMedian survival durationAbdominal computed tomographyPopulation-based patternsLong-term survivalIntensity of surveillanceOverall survivalMedian ageSurveillance guidelinesColorectal cancerMedicare databaseSecondary interventionsSurvival durationProcedure typeFrequent surveillanceHealthcare resources
2012
Patient Readmission and Mortality after Surgery for Hepato-Pancreato-Biliary Malignancies
Schneider E, Hyder O, Wolfgang C, Hirose K, Choti M, Makary M, Herman J, Cameron J, Pawlik T. Patient Readmission and Mortality after Surgery for Hepato-Pancreato-Biliary Malignancies. Journal Of The American College Of Surgeons 2012, 215: 607-615. PMID: 22921328, PMCID: PMC4051393, DOI: 10.1016/j.jamcollsurg.2012.07.007.Peer-Reviewed Original ResearchMeSH KeywordsAgedAged, 80 and overBiliary Tract NeoplasmsCohort StudiesDigestive System Surgical ProceduresFemaleHospital MortalityHumansLength of StayLiver NeoplasmsLogistic ModelsMaleMedicareMultivariate AnalysisPancreatic NeoplasmsPatient ReadmissionPostoperative ComplicationsRetrospective StudiesSEER ProgramSurvival AnalysisTreatment OutcomeUnited StatesConceptsRisk of readmissionHepatobiliary proceduresPancreatic proceduresHepatobiliary surgical proceduresMultiple preoperative comorbiditiesEnd Results-MedicareHigher inpatient mortalityPrimary surgical treatmentDays of dischargeIncidence of readmissionProlonged hospital stayProportion of patientsShort-term morbidityNumber of patientsPreoperative comorbiditiesHigher readmissionHospital morbidityHospital stayIndex hospitalAdditional morbidityInpatient mortalityMost patientsPatient agePatient comorbiditiesSurgical treatment